CIDRAP newsletters options
About 90% of cancer patients had adequate coronavirus antibodies after vaccination.
CARB-X announced today that it is awarding Swiss pharmaceutical company BioVersys up to $4.35 million to develop a new class of antibiotics to treat life-threatening infections caused by multidrug-resistant bacteria.
COVID-19 infection was 94% less likely in people previously infected than in those never infected, according to a research letter late last week in JAMA Internal Medicine. However, the researchers note, their study concluded before COVID-19 variants became dominant.
In a new poll, 62% of US adults saying they've gotten at least one dose, up from 56% in April.
"Our study does not necessarily mean that all mass events are safe."
The drop in cases has been slow in the Tokyo area, which will host the Olympics in late July.
Hospitalization, hypoxemia, pneumonia, and other complications were found more in children who contracted COVID-19 than in those who had seasonal flu, according to a study today in Pediatrics.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The Global Antibiotic Research and Development Partnership (GARDP), on behalf of the Drugs for Neglected Diseases initiative, issued a statement this week that called on World Health Organization (WHO) member states to strengthen their responses to antimicrobial resistance (AMR).
Also, Japanese officials are mulling extending the state of emergency for much of the country.
In the US, overdose-related cardiac deaths rose 42%, and in Ontario, opioid deaths climbed 135%.
As vaccinations increase, COVID-19 cases continue to drop across the country.
A randomized controlled trial of two inactivated (vero cell) COVID-19 vaccines made in China finds a vaccine efficacy of 73% in one and 78% in the other, according to a study yesterday in JAMA.
The whole-virus inactivated vaccines were developed with strains of the virus taken from patients in Wuhan, China.
CARB-X announced today that it is awarding up to $3.9 million to a Danish microbiome biotechnology company to develop a CRISPR-based drug to prevent Escherichia coli infections in cancer patients.
Four of the five countries with the most cases last week were in the Americas.
All airline passengers, including those fully vaccinated, are required to wear masks at least through Sep 13.
But the results also show some children may benefit from longer therapy.
The experts ask for a review similar to a WHO assessment before the 2016 Games.
Data from Germany support COVID-19 superspreading theory.
An analysis of US nursing home surveys shows substantial progress in antibiotic stewardship element implementation, researchers with the Centers for Disease Control and Prevention (CDC) reported today in Infection Control & Hospital Epidemiology.
